- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07597434
Perception, Risk Behaviour, and Attitudes Related to Non-communicable Disease
Understanding of the Perception, Risk Behaviour, and Attitudes Related to Non-communicable Disease Among Adolescents and Young Adults: An Exploratory Study
The study is to explore the understanding of the perception, risk behaviour, and attitudes related to non-communicable diseases among adolescents and young adults. The objectives of the study are:
- To investigate the understanding of non-communicable diseases among adolescents and young adults;
- To identify the prevalence of health-risk behaviours among adolescents and young adults;
- To examine the attitudes and behaviours to prevent non-communicable diseases among adolescents and young adults
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
Chronic diseases, also known as non-communicable diseases (NCDs), are the leading causes of global morbidity and mortality, accounting for around 74% of all deaths worldwide. Cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes contribute to over 80% of premature NCD-related deaths. The World Health Organization identifies four key modifiable behavioural risk factors-tobacco use, harmful alcohol consumption, unhealthy diets, and physical inactivity-as major contributors to NCDs. Evidence shows that most premature deaths from NCDs are preventable through targeted interventions and sustainable lifestyle changes. In Hong Kong, the burden of NCDs is growing, driven by an aging population. The Hospital Authority projects a 50% increase in NCD cases among the middle-aged, rising from 2 million in 2019 to 3 million by 2039, posing a serious challenge to the healthcare system. In response, the government has pledged to strengthen district-based primary healthcare services, including establishing health centres across all districts and launching the Chronic Disease Co-Care Pilot Scheme in 2023 for adults aged 45 and above.
However, adolescence represents a critical developmental window characterized by rapid biological, cognitive, and emotional changes, as well as heightened exposure to social stressors. This stage is particularly vulnerable to the adoption of risk behaviours that often persist into adulthood and contribute to chronic health conditions. Notably, 97.4% of smokers in Hong Kong began smoking before age 30, underscoring the importance of early intervention. These findings highlight the need to initiate education and screening efforts at a younger age. The adage "an ounce of prevention is worth a pound of cure" is especially pertinent in public health. Reflecting this, the Hong Kong Government is transitioning its healthcare model from treatment-focused to prevention-oriented. Prioritizing early intervention during youth is essential for promoting lifelong health and well-being and represents one of the most effective strategies for reducing the prevalence of NCDs in Hong Kong.
Aim of Study
The aim of the study is to explore the understanding of the perception, risk behaviour, and attitudes related to non-communicable diseases among adolescents and young adults. The objectives of the study are:
- To investigate the understanding of non-communicable diseases among adolescents and young adults;
- To identify the prevalence of health-risk behaviours among adolescents and young adults;
- To examine the attitudes and behaviours to prevent non-communicable diseases among adolescents and young adults
Outcome measures Primary outcomes: Information on four major health-risk behaviours including tobacco use, harmful use of alcohol, an unhealthy diet and physical inactivity, and lifestyle practices associated with prevention and control of non-communicable diseases (NCDs)
In what way will the research contribute to knowledge or healthcare development? The findings of this study will contribute to the development of appropriate interventions that targeting adolescents and young adults with health-risk behaviours with the aim to help them quit health-risk behaviours and adopt a healthy lifestyle.
Study subjects Inclusion criteria
- Aged 18 to 45 years
- Able to speak Cantonese
Exclusion criteria
- Studying medical, nursing and healthcare-related courses or working in medical, nursing, and allied health fields
- Those who had been diagnosed with NCDs
How will subjects be identified and recruited: To enhance the representativeness of the sample, we aim to recruit participants from all the 18 districts in the community.
Measures: A modified behavioural health-risk factor survey was used to collect demographic data and information regarding health-risk behaviours. The survey was a checklist adopted from the Hong Kong Department of Health (www.chp.gov.hk/files/pdf/brfs_2015apr_en.pdf, accessed on 5 January 2021).
Methods of Data Analysis Data will be entered into SPSS for Windows (version 28). A logic check program will be installed for entry validation. Descriptive statistics such as frequency, percentage, and mean will be used to summarize the outcomes and other variables. Chi-square tests and t-tests will be used to compare outcome variables between subgroups. The Pearson product moment correlation coefficient will be used to investigate the interrelationships.
Undersøgelsestype
Tilmelding (Anslået)
Kontakter og lokationer
Studiekontakt
- Navn: Ho Cheung William Li, PhD
- Telefonnummer: +85239430889
- E-mail: williamli@cuhk.edu.hk
Studiesteder
-
-
-
Hong Kong, Hong Kong
- Rekruttering
- The Nethersole School of Nursing, The Chinese University of Hong Kong
-
Kontakt:
- Ho Cheung William Li, PhD
- Telefonnummer: +85239430889
- E-mail: williamli@cuhk.edu.hk
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
Tager imod sunde frivillige
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- (1) Aged 18 to 45 years
- (2) Able to speak Cantonese
Exclusion Criteria:
- (1) Studying medical, nursing and healthcare related courses or working in medical, nursing, and allied health fields
- (2) Those who had been diagnosed with non-communicable diseases
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Information on four major health risk behaviours
Tidsramme: Baseline
|
Information on four major health risk behaviours including tobacco use, harmful use of alcohol, an unhealthy diet and physical inactivity, and lifestyle practices associated with prevention and control of non-communicable diseases (NCDs), will be collected by using a modify behavioural health-risk factor survey.
Data on tobacco use, alcohol consumption, fruit and vegetable intake, physical activity levels, and relevant lifestyle practices will be analysed to determine whether participants meet the World Health Organization (WHO) targets for the prevention and control of non-communicable diseases.
|
Baseline
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 0962
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Ikke-smitsomme sygdomme
-
Estrella Biopharma, Inc.Eureka Therapeutics Inc.RekrutteringLymfom | Lymfom, Non-Hodgkin | Non-Hodgkins lymfom | Non-Hodgkin lymfom | Refraktær B-celle non-Hodgkin lymfom | Refraktær non-Hodgkin lymfom | Højgradigt B-celle lymfom | CNS lymfom | Lymfomer Non-Hodgkins B-celle | Recidiverende non-Hodgkin lymfom | Lymfom, Non-Hodgkins | Stort B-celle lymfom | Lymfom, Non-Hodgkins... og andre forholdForenede Stater
-
Caribou Biosciences, Inc.RekrutteringLymfom | Lymfom, Non-Hodgkin | B-celle lymfom | Non Hodgkin lymfom | Refraktær B-celle non-Hodgkin lymfom | Recidiverende non-hodgkin lymfom | B-celle non-Hodgkins lymfomForenede Stater, Australien, Israel
-
Stanford UniversityNational Institutes of Health (NIH); AmgenAfsluttetLymfom, Non-Hodgkin | Lymfomer: Non-Hodgkin | Lymfomer: Non-Hodgkin perifer T-celle | Lymfomer: Non-Hodgkin kutan lymfom | Lymfomer: Non-Hodgkin diffuse store B-celler | Lymfomer: Non-Hodgkin follikulært / indolent B-celle | Lymfomer: Non-Hodgkin kappecelle | Lymfomer: Non-Hodgkin Marginal Zone | Lymfomer...Forenede Stater
-
Chongqing Precision Biotech Co., LtdRekrutteringNon Hodgkin lymfom | Refraktær non-Hodgkin lymfom | Recidiverende non-Hodgkin lymfomKina
-
Marker Therapeutics, Inc.RekrutteringHodgkin lymfom | Non Hodgkin lymfom | Hodgkin lymfom, voksen | Non-Hodgkin lymfom, voksen | Non-Hodgkin lymfom, refraktær | Non-Hodgkin lymfom, tilbagefald | Hodgkins lymfom, recidiverende, voksenForenede Stater
-
Mayo ClinicRekrutteringIndolent B-celle non-Hodgkin lymfom | Tilbagevendende indolent non-Hodgkin-lymfom | Refraktært indolent non-Hodgkin lymfom | Tilbagevendende indolent B-celle non-Hodgkin lymfom | Refraktært indolent B-celle non-Hodgkin lymfomForenede Stater
-
City of Hope Medical CenterNational Cancer Institute (NCI)RekrutteringRefraktær B-celle non-Hodgkin lymfom | Tilbagevendende B-celle non-Hodgkin lymfom | Højgradig B-celle non-Hodgkins lymfom | Mellemklasse B-celle non-Hodgkins lymfomForenede Stater
-
National Cancer Institute (NCI)Aktiv, ikke rekrutterendeRefraktær B-celle non-Hodgkin lymfom | Refraktær T-celle non-Hodgkin lymfom | Tilbagevendende B-celle non-Hodgkin lymfom | Tilbagevendende transformeret non-Hodgkin-lymfom | Tilbagevendende non-Hodgkin-lymfom | Refraktær non-Hodgkin lymfom | Tilbagevendende T-celle non-Hodgkin lymfom | Tilbagevendende... og andre forholdForenede Stater
-
Joseph TuscanoSpectrum Pharmaceuticals, IncAktiv, ikke rekrutterendeRecidiverende non-hodgkin lymfom | Refraktær non-hodgkin lymfomForenede Stater
-
GC Cell CorporationUkendtRefraktær non-Hodgkin lymfom | Recidiverende non-hodgkin lymfomKorea, Republikken